Neuronetics (STIM) Share-based Compensation (2017 - 2026)
Neuronetics (STIM) posted quarterly Share-based Compensation of $1.7 million for Q1 2026, up 16.14% year-over-year from $1.4 million in Q1 2025, and down 23.11% quarter-over-quarter from $2.2 million in Q4 2025.
Neuronetics (STIM) Share-based Compensation (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has reported Share-based Compensation for 10 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 16.14% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $7.1 million (up 24.05% YoY), while the FY2025 annual figure was $6.8 million, up 22.24% from the prior year.
- Share-based Compensation declined to $1.7 million in Q1 2026 per STIM's latest filing, from $2.2 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $2.3 million in Q1 2022 and bottomed at $1.3 million in Q4 2024.
- Historically, Share-based Compensation has averaged $1.8 million across 5 years, with a median of $1.8 million in 2023.
- Annual changes were most pronounced in 2024 — Share-based Compensation decreased 25.87% — and 2025, when it surged 70.12%.
- Neuronetics' Share-based Compensation stood at $2.1 million in 2022, then declined by 23.05% to $1.6 million in 2023, then slipped by 21.16% to $1.3 million in 2024, then soared by 70.12% to $2.2 million in 2025, then decreased by 23.11% to $1.7 million in 2026.
- Business Quant data shows STIM's Share-based Compensation at $1.7 million in Q1 2026, $2.2 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.61 Bn | 197.01 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 127.33 Bn | 123.85 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 119.23 Bn | 110.01 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 74.53 Bn | 73.99 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.84 Bn | 47.59 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 35.08 Bn | 33.14 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.86 Bn | 31.75 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.26 Bn | 22.94 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Neuronetics | 224.65 Mn | 205.22 Mn | 21.22 Mn | 688,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 688,000.00 |
| Jun 30, 2026 | 688,000.00 |
| Mar 31, 2026 | 1.68 Mn |
| Mar 31, 2026 | 1.68 Mn |
| Dec 31, 2025 | 2.18 Mn |
| Dec 31, 2025 | 2.18 Mn |
| Sep 30, 2025 | 1.41 Mn |
| Sep 30, 2025 | 1.41 Mn |
| Jun 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | 1.81 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Mar 31, 2024 | 1.34 Mn |